Sunday, December 31, 2023 12:38:59 AM
Take a look at one of them: Specialist, Manufacturing Automation. And the job description is full of fascinating key words.
https://jobs.merck.com/us/en/job/R271246/Specialist-Manufacturing-Automation
The Building 50 Live Virus Vaccine Filling Facility project team is seeking a highly motivated individual to fill an open position to support the start-up of a new vaccine filling & lyophilization facility at the West Point site.
I assume everyone knows that poly-iclc is called "mimic virus" which basically acts like real virus to induce immune response. I suspect we can correlate "live virus" with "mimic virus". Now let us take a look at the Building 50 first.
And then check out the five steps in producing poly-iclc with controlled chain length. It seems to me that building 50 could be related to the manufacturing of poly-iclc.
Next we need to check out if poly-iclc has to be stored in vials since there is a keyword "filling". Indeed, Hiltonol is stored in vials according to the following link.
https://www.cancerresearch.org/media-room/2011/cri-announces-investment-with-oncovir
Through the collaboration, CVAF will provide $450,000 to Oncovir to help fund the manufacture of clinical grade Hiltonol®. As part of the agreement, 10,000 vials of Hiltonol® will be dedicated exclusively for use in 10 to 15 early- and mid-phase clinical trials designed and conducted within the CRI/LICR Cancer Vaccine Collaborative (CVC), a coordinated global network of 19 academic clinical trial sites and advanced immunological monitoring laboratories.
Does one need a lottery mindset to think that Building 50 at Merck West Campus will be used to produce poly-iclc? BTW, I never play lottery. I heard one has more probability to land on the surface of the moon than to win the lottery.
Bear in mind once the manufacturing is started, it is going to operate 24/7 nonstop. If it is about poly-iclc, Merck is going to manufacture a lot.
This team rotates through the vaccine filling and packaging departments at the West Point site providing quality and compliance oversight to our 24 / 7 manufacturing operations
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173492455
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173499481
BREAKING🚨 Brokerage Firm TradeStation Confirms a Share Imbalance and Potential Counterfeit Shares in MMTLP
— X Market News🚨 (@xMarketNews) December 29, 2023
“The NBH certificate that TradeStation received excluded a large number of NBH shares that had been lent to other broker-dealers… This means that we will not be able to…
$MMTLP it's been a year, 5 federal lawsuits, 2 state lawsuits, 2 Congressional hearings - COMPLETE and ABSOLUTE STONEWALLING. I think it's time for the @DOJCrimDiv to start looking into Federal CRIMINAL RICO charges against numerous agencies and Brokers. This is completely…
— Mark R. Basile,Esq. (@BasileEsq) December 26, 2023
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
